Plant Health Care Plc ProAct® Wins Top Industry Award

Chris Richards, Executive Chairman and Interim CEO of Plant Health Care noted: “This award is recognition that Plant Health Care, as a science-based company, can bring new benefits to growers with low toxicity, biological products. We now plan to take these results from Spain into other key citrus growing areas, such as Florida, South Africa and North Africa.”

Plant Health Care Plc (LON:PHC), a leading provider of novel patent-protected biological products to global agriculture markets, today announced ProAct was named Best New Biological Product on 12th November in London at the Agrow Awards.

Highlights:

– ProAct (Harpin ab) has been recognised as Best New Biological Product at the Agrow Awards, a prestigious global industry event

– Research has shown how ProAct works to improve citrus quality, leading to increased production of export quality fruit

– Plant Health Care is leveraging these results to drive sales into citrus and other fruits into export fruit markets in the Americas and Africa

ProAct, which is based on Harpin ab, improves the quality of fruit, so that more are graded for export, thereby increasing returns to growers. Research at Instituto Valenciano de Investigaciones Agrarias, in collaboration with Plant Health Care, showed that ProAct stimulates the mobilisation of calcium in the plant cell wall of citrus fruits, leading to a stronger peel, which is less susceptible to fruit splitting. Moreover ProAct, as a biological product, is certified for residue free fruit and vegtables.

Angel Marin, General Manager of Plant Health Care España S.A., received the award on behalf of the Company.

Harpin ab, the active ingredient in ProAct, has been used on over 13 million acres on multiple crops. Sales have been growing at over 20% a year for the past 5 years.

Click to view all articles for the EPIC:
Or click to view the full company profile:
    Facebook
    Twitter
    LinkedIn
    Plant Health Care Plc

    More articles like this

    Plant Health Care Plc

    Plant Health Care appoint new Board directors

    Plant Health Care (LON:PHC) has announced three new Board appointments with effect from 1st November 2019. Mr Guy van Zwanenberg FCA will join the PHC Board as a Non-executive Director. He will take over as Chair of the

    Plant Health Care Plc

    Plant Health Care Progress with PREtec field trials in Brazil

    Plant Health Care (LON:PHC), a leading provider of novel patent-protected biological products to global agriculture markets, has today provided the following update in relation to the 2018/19 field trials of the PREtec peptide PHC279 for the

    Plant Health Care Plc

    Plant Health Group plc New Distribution Agreement for Harpin αß

    Plant Health Care plc (LON:PHC), a leading provider of novel patent-protected biological products to global agriculture markets, today announced a new distribution agreement with Wilbur-Ellis Company LLC, a leading U.S. agriculture distributor, for exclusive access to

    Path Investments Plc

    Path Investments plc Update on Heads of Agreement

    Path Investments plc (LON: PATH) today provided an update regarding the Heads of Agreement with ARC Marlborough Pty Limited (“ARC”) in relation to the proposed acquisition of ARC by the Company (the “Proposed Transaction”) announced on

    Plant Health Care Plc

    Plant Health Care Made exciting progress in 2018

    Chris Richards, Plant Health Care Interim CEO, commented: “Plant Health Care continued to make exciting progress in 2018, in spite of recently announced set-backs. The launch of our new corn product in the US holds great

    Plant Health Care Plc

    Plant Health Care to present at Mello London

    Plant Health Care (LON: PHC), a leading provider of novel patent-protected biological products to global agriculture markets, today announced that the Company will be presenting at the Mello London investor conference on Tuesday 27 November 2018